What does CUSIP 05070R104 represent in this 13F holders report?

CUSIP 05070R104 is the security identifier for BOLD - AUDENTES THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held BOLD - AUDENTES THERAPEUTICS INC - COM in Q1 2019?

137 institutional investors reported BOLD - AUDENTES THERAPEUTICS INC - COM for Q1 2019. Use the holders table for investor-level position and value details.

AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class: Equity / COM
Total 13F shares: 43,738,394
Share change: +684,869
Total reported value: $1,706,572,305
Put/Call ratio: 28%
Price per share: $39.02
Number of holders: 137
Value change: +$30,876,825
Number of buys: 74
Number of sells: 53

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2019
Previous quarter: Q4 2018

Recent filing periods for CUSIP 05070R104:

Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q1 2019

As of 31 Mar 2019, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,738,394 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Redmile Group, LLC, FMR LLC, Partner Fund Management, L.P., VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, GILDER GAGNON HOWE & CO LLC, and GREAT POINT PARTNERS LLC. This page lists 137 institutional shareholders reporting positions in this security for the Q1 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.